• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Osiris Therapeutics Inc

+ Add to Watchlist

OSIR:US

12.3900 USD 0.4100 3.20%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Osiris Therapeutics Inc (OSIR)

Open: 12.7500 Day's Range: 12.3300 - 13.0300 Volume: 272,435
Previous Close: 12.8000 52wk Range: 10.0000 - 27.4000 1-Yr Rtn: +12.94%

Stock Chart for OSIR

No chart data available.
  • OSIR:US 12.3900
  • 1D
  • 1M
  • 1Y
12.8000
Interactive OSIR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OSIR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.2550
Est. PEG Ratio -
Market Cap (M USD) 424.00
Shares Outstanding (M) 34.22
30 Day Average Volume 276,410
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OSIR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for OSIR

Osiris Therapeutics, Inc. researches and develops therapeutic products for the regeneration of human connective tissues. The Company is focusing its initial product development efforts on the regeneration of bone marrow stroma following high-dose cancer chemotherapy, and on the regeneration of bone in long bone and spinal defects.

Lode DebrabanderePresident/CEOPhilip R Jacoby JrCFO/Treasurer/Secretary
Alla DanilkovitchVP:Research & Development
More Company Profile & Key Executives for OSIR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil